Accent Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of Novel KIF18A Inhibitor ATX-295 and Receives FDA Fast Track Designation for Lead Assets ATX-295 and DHX9 Inhibitor ATX-559 PressReach · Apr 15, 2025
MGI Tech Celebrates 10 Years of DNBSEQ™ Technology: Driving Genomics Forward with Speed, Scale, and Accessibility PressReach · Apr 14, 2025
Over 3 million children died from AMR-related infections in 2022, major study shows PressReach · Apr 13, 2025
Fruitful translation of HKBU's innovative research projects takes centre stage at International Exhibition of Inventions Geneva PressReach · Apr 13, 2025
STAGO ANNOUNCES "THE IMPORTANCE OF ROUTINE COAGULATION TESTING" EDUCATIONAL WEBINAR PressReach · Apr 12, 2025
Ellen M. DiPaola Honored as the 2025 Aging Life Care Association® Distinguished Ambassador in Aging Award for Dedication to Honoring Health Care Choices PressReach · Apr 12, 2025
Nauticus Robotics Announces Timing of 2024 Investor Earnings Conference Call PressReach · Apr 12, 2025
